Partner, Health Care - Generics, Biosimilars & Strategic Transformation

Description du poste Partner, Health Care - Generics, Biosimilars & Strategic Transformation à Bleicherweg 62 8002 Zürich

<p> <strong>
Who We Are</strong> </p> <p>
Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities.
BCG was the pioneer in business strategy when it was founded in 1963.
Today, we help clients with total transformation-inspiring complex change, enabling organizations to grow, building competitive advantage, and driving bottom-line impact. <br><br>
To succeed, organizations must blend digital and human capabilities.
Our diverse, global teams bring deep industry and functional expertise and a range of perspectives to spark change.
BCG delivers solutions through leading-edge management consulting along with technology and design, corporate and digital ventures—and business purpose.
We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, generating results that allow our clients to thrive.&nbsp;</p> <p>"
Inspiring the bold who advance the health of care."
BCG’s global Health Care team works across the health care ecosystem to deliver sustainable competitive&nbsp;advantage&nbsp;for our clients, to create value for society, and to improve outcomes for patients.
And we are passionate about it.
We are committed to developing new insights and, through our customized approach, helping organizations navigate rapid change in today’s digital world.
Our global health care team serves top companies across the health care industry - including biopharmaceuticals, medical technologies and devices, health care providers, payers, services, and global health.
BCG’s Health Care Practice is the third largest industry practice globally, and second in the US. <br><br></p> <p> <strong>
What You'll Do</strong> </p> <ul> <li>
Own and expand senior executive relationships across global pharmaceutical and biotechnology companies, positioning the firm as the trusted thought partner on enterprise-wide strategic priorities. </li> </ul> <ul> <li>
Lead high-stakes strategy and transformation programs spanning corporate strategy, portfolio optimization, R&amp;
D model redesign, and commercial performance acceleration—particularly within the off-patent and&nbsp;biosimilars&nbsp;landscape. </li> </ul> <ul> <li>
Drive proactive business development by&nbsp;identifying&nbsp;inflection points in the generics and specialty pharma markets, converting strategic dialogue into sustainable revenue streams. </li> </ul> <ul> <li>
Serve as&nbsp;overall&nbsp;engagement leader for complex, international, multi-workstream programs, ensuring disciplined governance, financial oversight, and measurable value delivery. </li> </ul> <ul> <li>
Advise&nbsp;healthcare-focused private equity investors across the full deal lifecycle, including strategic due diligence, investment thesis validation, and post-acquisition value creation. </li> </ul> <ul> <li>
Build and scale priority accounts into long-term partnerships, expanding footprint across strategy, R&amp;
D, operations, and commercial functions. </li> </ul> <ul> <li>
Contribute to practice differentiation through development of proprietary insights, market perspectives, and executive-level forums within the global&nbsp;generics&nbsp;and&nbsp;biosimilars&nbsp;ecosystem. <br><br></li> </ul> <p> <strong>
What You'll Bring</strong> </p> <ul> <li>
Significant senior leadership experience in top-tier strategy consulting within Life Sciences, complemented by operational exposure and a strong understanding of global pharmaceutical business models. </li> </ul> <ul> <li>
Recognized&nbsp;expertise&nbsp;in generics and biosimilars, including portfolio strategy, competitive positioning, lifecycle management, and operating model evolution in a rapidly shifting regulatory and pricing environment. </li> </ul> <ul> <li>
Demonstrated success leading large-scale R&amp;
D&nbsp;(especially with deep&nbsp;expertise&nbsp;in the&nbsp;generics&nbsp;and biosimilar space)&nbsp;and enterprise transformation initiatives, aligning cross-functional stakeholders around clear strategic direction and execution roadmaps. </li> </ul> <ul> <li>
Proven ability to originate, grow, and sustain major client accounts, with established credibility at CEO,&nbsp;
CxO, and senior functional leadership levels. </li> </ul> <ul> <li>
Strong&nbsp;track record&nbsp;supporting private equity transactions in healthcare&nbsp;(across generics, biosimilar, and CDMO space), combining strategic rigor with pragmatic value-creation planning. </li> </ul> <ul> <li>
Exceptional executive presence and communication capabilities, with the ability to challenge, influence, and shape board-level decision making. </li> </ul> <ul> <li>
Commitment to talent development and practice building, including mentorship of senior teams and active contribution to intellectual capital and market positioning.&nbsp;</li> </ul> <p> <strong>
Who You'll Work With</strong> </p> <p>
Boston Consulting Group is an Equal Opportunity Employer.
All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity / expression, national origin, disability, protected veteran status, or any other characteristic protected under national, provincial, or local law, where applicable, and those with criminal histories will be considered in a manner consistent with applicable state and local laws. <br><br>
BCG is an E - Verify Employer. <a href="https://www.bcg.com/en-us/topic/everify.aspx"> <u>
Click here </u> </a>for more information on E-Verify.&nbsp;</p>